The worldwide dementia medications market is anticipated to rise as more clinical studies for new dementia treatments are conducted. For instance, a study from Monash University in Australia that has shown encouraging results as a novel therapy for dementia patients under the age of 60 has the potential to stabilise escalating behavioural issues and reverse the disease's impact on brain shrinkage. It is the second clinical experiment to suggest that sodium selenate, a medication, may delay cognitive decline and neuronal damage caused by dementia and Alzheimer's disease. The Monash Phase 1 trial demonstrated that sodium selenate is safe and well-tolerated in patients with bvFTD over a 12-month period. This study was the only one in Australia that focused on this particular behavioural form of frontotemporal dementia (bvFTD) and one of a select few globally.
Global Dementia Drugs Market is estimated to be valued at US$ 20,677.0 million in 2022 and is expected to exhibit a CAGR of 8.5% during the forecast period (2022-2030).
Leading Companies in the Dementia Drugs Industry :
1. Eisai, Inc.
Eisai Co., Ltd. offers pharmaceutical products in Japan. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan. In January, 2023 Eisai Co., Ltd. and Biogen Inc. announced that under the Accelerated Approval Pathway the U.S. Food and Drug Administration (FDA) has approved lecanemab-irmb (Brand Name in the U.S.: LEQEMBI™) 100 mg/mL injection for intravenous use, a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble (“protofibril”)* and insoluble forms of amyloid beta (Aβ) for the treatment of Alzheimer’s disease (AD).
2 Forest Laboratories, Inc.
Forest Laboratories, Inc. develops, manufactures, and sells both brand-name and generic prescription and nonprescription drugs. Forest Laboratories was founded in 1956 as a small laboratory service company.The company has headquarters situated in New York. USA.
3. Eli Lilly and Company
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
4. Novartis AG
Novartis is structured and well developed company that helps deliver innovative products, and respond to new opportunities and risks. Headquarters is located in Basel, Baselstadt. In December, 2022 announced the European Commission (EC) approved Pluvicto® (INN: lutetium (177Lu) vipivotide tetraxetan), a targeted radioligand therapy.
5. Sanofi S.A.
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions and was founded in 1973. The company is headquartered in Paris, France and is operational in 100 plus countries. Sanofi and Innate Pharma SA announced in December, 2022 an expansion of their collaboration, with Sanofi licensing a natural killer (NK) cell engager program targeting B7H3 from Innate’s ANKET (Antibody-based NK Cell Engager Therapeutics) platform.
6. AstraZeneca GmbH
AstraZeneca PLC was incorporated in 1992.The company is headquartered in Cambridge, the United Kingdom and operational in more than 100 countries. AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. In December, 2022 AstraZeneca’s Calquence (acalabrutinib), a selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in Japan for the treatment of adult patients with treatment-naïve chronic lymphocytic leukaemia (CLL)
7. F. Hoffmann-La Roche
Roche Holding AG engages in the pharmaceuticals and diagnostics. The company was founded in 1896 and is headquartered in Basel, Switzerland.
8. Merck & Co., Inc.
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
9. Pfizer Inc.
Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sell biopharmaceutical products worldwide. In December, 2022 announced the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine as the third 3-µg dose in the three-dose primary series for children 6 months through 4 years of age.
10. Teva Pharmaceuticals Industries Ltd.
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
*Definition- One of the most common neurodegenerative diseases, dementia causes a variety of behavioural changes in its victims. The disease's initial symptoms, such as memory loss or other cognitive impairment, can deteriorate with time.
